INVO Fertility, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 204.11 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2023-04-17
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2022-12-31 was 16.25K shares, a 85.43% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2022-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2022-06-30 was 28.50K shares, a 190.64% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2022-03-31 was 159.36K shares, a 122.08% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2022 was 204.11K shares, a 3.05% increase from fiscal 2021.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2021 was 198.06K shares, a 181.73% increase from fiscal 2020.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2020 was 70.30K shares, a 462.42% increase from fiscal 2019.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2019 was 12.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | 16.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | 16.25K shares derived: sum of 2 quarters · filed 2023-04-17 | 44.75K shares derived: sum of 3 quarters · filed 2023-04-17 | 204.11K shares 10-K · filed 2023-04-17 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 28.50K shares derived: sum of 2 quarters · filed 2022-11-14 | 187.86K shares 10-Q · filed 2022-11-14 | 299.36K shares derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-06-30 | 28.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 187.86K shares 10-Q · filed 2022-08-15 | 299.36K shares derived: sum of 3 quarters · filed 2022-08-15 | 304.36K shares derived: sum of 4 quarters · filed 2022-08-15 | |
| 2022-03-31 | 159.36K shares 10-Q · filed 2022-05-16 | 270.86K shares derived: sum of 2 quarters · filed 2022-05-16 | 275.86K shares derived: sum of 3 quarters · filed 2022-05-16 | 285.67K shares derived: sum of 4 quarters · filed 2022-05-16 | |
| 2021-12-31 | 111.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 116.50K shares derived: sum of 2 quarters · filed 2022-03-31 | 126.31K shares derived: sum of 3 quarters · filed 2022-03-31 | 198.06K shares 10-K · filed 2022-03-31 | |
| 2021-09-30 | 5.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 14.81K shares derived: sum of 2 quarters · filed 2021-11-15 | 86.56K shares 10-Q · filed 2021-11-15 | 100.36K shares derived: sum of 4 quarters · filed 2021-11-15 | |
| 2021-06-30 | 9.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 81.56K shares 10-Q · filed 2021-08-16 | 95.36K shares derived: sum of 3 quarters · filed 2021-08-16 | 81.45K shares derived: sum of 4 quarters · filed 2021-08-16 | |
| 2021-03-31 | 71.76K shares 10-Q · filed 2021-05-17 | 85.55K shares derived: sum of 2 quarters · filed 2021-05-17 | 71.65K shares derived: sum of 3 quarters · filed 2021-05-17 | -1.26M shares derived: sum of 4 quarters · filed 2021-05-17 | |
| 2020-12-31 | 13.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -110.00 shares derived: sum of 2 quarters · filed 2021-03-30 | -1.33M shares derived: sum of 3 quarters · filed 2021-03-30 | 70.30K shares 10-K · filed 2021-03-30 | |
| 2020-09-30 | -13.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -1.34M shares derived: sum of 2 quarters · filed 2020-11-16 | 56.51K shares 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | -1.33M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 70.41K shares 10-Q · filed 2020-08-13 | |||
| 2020-03-31 | 1.40M shares 10-Q · filed 2020-05-15 | ||||
| 2019-12-31 | 12.50K shares 10-K · filed 2021-03-30 | 400.00K shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |